Compare Heron Therapeutics Inc (HRTX) vs Vipshop Holdings Ltd - ADR (VIPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Vipshop Holdings Ltd - ADR — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while Vipshop Holdings Ltd - ADR trades at $14.53 (market cap $7.01B). The key difference: Vipshop Holdings Ltd - ADR is far larger — about 76.6× Heron Therapeutics Inc's market cap, and Vipshop Holdings Ltd - ADR pays a 4.25% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | VIPS | |
|---|---|---|
Market Cap | $91.46M | $7.01B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.96 | $20.68 |
52-Week Low | $0.39 | $12.92 |
Enterprise Value | $189.36M | $3.60B |
Dividend Yield | — | 4.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.
Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.
Vipshop (VIPS) trades at $14.56, up 0.41% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 7.07% net income margin and attractive valuation ratios including a P/E of 6.61. Recent Q1 2026 earnings met expectations, and the company is pursuing growth through an outlet store REIT spin-off strategy. Revenue has stabilized around $106 billion after a slight decline from 2023 peaks.
Outlook remains positive given low valuations and analyst consensus, but risks include competitive pressures in Chinese e-commerce and macroeconomic headwinds. The stock offers value opportunity if execution on outlet strategy drives growth, though investors should monitor revenue trends and industry challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Vipshop Holdings Ltd - ADR
Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →
